At the same time, the company decided to withdraw the marketing authorizations for the serum in Europe.
“Since several variants of the COVID-19 vaccine have been developed in the meantime, there is a surplus of updated vaccines available,” AstraZeneca representatives said.
The company stated that, in this context, it is experiencing a decrease in demand for its anti-COVID vaccine, which is no longer manufactured or supplied.
According to The Telegraph, the first publication to report on the situation, the request to withdraw the vaccine was made on March 5 and took effect on Tuesday, May 7.
The pharmaceutical company recently acknowledged that one of the side effects of its COVID-19 vaccine could be thrombocytopenia thrombocytopenia syndrome, which causes blood clots and low platelet counts.
Currently, AstraZeneca is focusing on vaccines against the respiratory syncytial virus and anti-obesity drugs, the quoted sources note.
Photo: Hepta
Follow us on Google News
Tags: AstraZeneca Withdraws COVID19 Vaccine Worldwide Reason Invoked Company
-
